Pablo Barreiro

Research interests

Publications

• Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations

  AIDS · 2010 · 10.1097/qad.0b013e32833202e2

• Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations

  AIDS · 2010 · 10.1097/qad.0b013e32833202e2

• Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations

  AIDS · 2010 · 10.1097/qad.0b013e32833202e2

• Viral hepatitis and HIV co-infection

  Antiviral Research · 2009 · 10.1016/j.antiviral.2009.10.021

• Viral hepatitis and HIV co-infection

  Antiviral Research · 2009 · 10.1016/j.antiviral.2009.10.021

• Viral hepatitis and HIV co-infection

  Antiviral Research · 2009 · 10.1016/j.antiviral.2009.10.021

• Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir

  AIDS · 2009 · https://doi.org/10.1097/qad.0b013e3283262a64

• Antiretroviral drugs and liver injury

  AIDS · 2008 · 10.1097/qad.0b013e3282f0e2fd

• Antiretroviral drugs and liver injury

  AIDS · 2008 · 10.1097/qad.0b013e3282f0e2fd

• Antiretroviral drugs and liver injury

  AIDS · 2008 · 10.1097/qad.0b013e3282f0e2fd

• Role of Weight-Based Ribavirin Dosing and Extended Duration of Therapy in Chronic Hepatitis C in HIV-Infected Patients: The PRESCO Trial

  AIDS Research and Human Retroviruses · 2007 · 10.1089/aid.2007.0011

• Role of Weight-Based Ribavirin Dosing and Extended Duration of Therapy in Chronic Hepatitis C in HIV-Infected Patients: The PRESCO Trial

  AIDS Research and Human Retroviruses · 2007 · 10.1089/aid.2007.0011

• Hepatotoxicity of Antiretroviral Drugs Is Reduced after Successful Treatment of Chronic Hepatitis C in HIV‐Infected Patients

  The Journal of Infectious Diseases · 2007 · 10.1086/520092

• Hepatotoxicity of Antiretroviral Drugs Is Reduced after Successful Treatment of Chronic Hepatitis C in HIV‐Infected Patients

  The Journal of Infectious Diseases · 2007 · 10.1086/520092

• Role of Weight-Based Ribavirin Dosing and Extended Duration of Therapy in Chronic Hepatitis C in HIV-Infected Patients: The PRESCO Trial

  AIDS Research and Human Retroviruses · 2007 · 10.1089/aid.2007.0011

• Hepatotoxicity of Antiretroviral Drugs Is Reduced after Successful Treatment of Chronic Hepatitis C in HIV‐Infected Patients

  The Journal of Infectious Diseases · 2007 · 10.1086/520092

• Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia

  AIDS · 2006 · 10.1097/qad.0b013e328011d7c1

• Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia

  AIDS · 2006 · 10.1097/qad.0b013e328011d7c1

• Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia

  AIDS · 2006 · 10.1097/qad.0b013e328011d7c1

• Severe Liver Disease Associated With Prolonged Exposure to Antiretroviral Drugs

  JAIDS Journal of Acquired Immune Deficiency Syndromes · 2006 · https://doi.org/10.1097/01.qai.0000221683.44940.62

• Influence of 516G>T Polymorphisms at the Gene Encoding the CYP450-2B6 Isoenzyme on Efavirenz Plasma Concentrations in HIV-Infected Subjects

  Clinical Infectious Diseases · 2005 · 10.1086/429327

• Influence of 516G>T Polymorphisms at the Gene Encoding the CYP450-2B6 Isoenzyme on Efavirenz Plasma Concentrations in HIV-Infected Subjects

  Clinical Infectious Diseases · 2005 · 10.1086/429327

• Influence of 516G>T Polymorphisms at the Gene Encoding the CYP450-2B6 Isoenzyme on Efavirenz Plasma Concentrations in HIV-Infected Subjects

  Clinical Infectious Diseases · 2005 · 10.1086/429327

• Analyzing Sleep Abnormalities in HIV‐Infected Patients Treated with Efavirenz

  Clinical Infectious Diseases · 2004 · 10.1086/380791

• Analyzing Sleep Abnormalities in HIV‐Infected Patients Treated with Efavirenz

  Clinical Infectious Diseases · 2004 · 10.1086/380791

• Analyzing Sleep Abnormalities in HIV‐Infected Patients Treated with Efavirenz

  Clinical Infectious Diseases · 2004 · 10.1086/380791

• Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients

  AIDS · 2003 · 10.1097/00002030-200305020-00011

• Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients

  AIDS · 2003 · 10.1097/00002030-200305020-00011

• Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients

  AIDS · 2003 · 10.1097/00002030-200305020-00011

• Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy

  AIDS · 2000 · https://doi.org/10.1097/00002030-200005050-00006

Current projects

No projects listed.